If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,460.00    74.00 (3.10%)
Bid:
2,449.00
Ask:
2,450.00
Spread: 1.00 (0.041%)
Market Cap: £29.67b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Scrip Alternative

28 Aug 2018 17:37

RNS Number : 0546Z
SSE PLC
28 August 2018
 

SSE PLC

 

FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2018

SCRIP ALTERNATIVE

SSE plc was notified today that a total of 27,039 shareholders have elected to receive the final dividend for the year ended 31 March 2018 of 66.3 pence per ordinary share in respect of 213,890,054 ordinary shares in the form of Scrip dividend. This will result in a reduction in final dividend cash funding of £141,809,106.

A total of 11,316,873 new ordinary shares, fully paid, will be issued on 21 September 2018, representing an increase of 1.11% on the issued share capital (excluding treasury shares) on the dividend record date of 27 July 2018. The relevant Scrip Reference Share Price was 1,253 pence per ordinary share.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVLLFVRTEITFIT
Date   Source Headline
8th Dec 20251:14 pmRNSDirector/PDMR Shareholding
4th Dec 202511:44 amRNSHolding(s) in Company
4th Dec 20257:01 amRNSSSENT response to RIIO-T3 Final Determination
3rd Dec 202510:10 amRNSHolding(s) in Company
2nd Dec 20252:41 pmRNSHolding(s) in Company
1st Dec 20258:55 amRNSHolding(s) in Company
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 202512:42 pmRNSHolding(s) in Company
28th Nov 202512:36 pmRNSHolding(s) in Company
28th Nov 202512:32 pmRNSDirector/PDMR Shareholding
27th Nov 20259:57 amRNSHolding(s) in Company
17th Nov 202511:30 amRNSDirector/PDMR Shareholding
14th Nov 20253:45 pmRNSDirector/PDMR Shareholding
13th Nov 20255:30 pmRNSSSE
12th Nov 20256:19 pmRNSResult of Equity Issue
12th Nov 20257:01 amRNSRetail Offer by RetailBook
12th Nov 20257:00 amRNSInterim Results
12th Nov 20257:00 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
12th Nov 20257:00 amRNSStrategic Update
7th Nov 202512:51 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
24th Oct 20252:30 pmRNSHolding(s) in Company
9th Oct 202511:42 amRNSDirector/PDMR Shareholding
7th Oct 20254:08 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSNOTIFICATION OF CLOSED PERIOD
1st Oct 20257:01 amEQSTotal Voting Rights
25th Sep 202511:00 amRNSDirector/PDMR Shareholding
22nd Sep 202511:46 amRNSDirector/PDMR Shareholding
16th Sep 202512:00 pmRNSAdditional Listing
9th Sep 20254:21 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amEQSTVR-Total Voting Rights
29th Aug 20257:00 amRNSBlock Listing 6-Monthly Return
28th Aug 20254:56 pmRNSScrip Alternative
26th Aug 20255:33 pmRNSSSEN TRANSMISSION ISSUES NEW €750m GREEN BOND
8th Aug 202511:12 amRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202510:39 amRNSSCRIP Dividend
31st Jul 202510:38 amRNSHolding(s) in Company
29th Jul 20253:51 pmRNSHolding(s) in Company
25th Jul 202511:05 amRNSHolding(s) in Company
23rd Jul 202512:13 pmRNSHolding(s) in Company
21st Jul 20253:44 pmRNSDirector/PDMR Shareholding
21st Jul 202511:49 amRNSHolding(s) in Company
17th Jul 20253:49 pmRNSResult of AGM
17th Jul 20257:00 amRNSQ1 Trading Statement
11th Jul 202511:00 amRNSDirector/PDMR Shareholding
9th Jul 20254:38 pmRNSDirector/PDMR Shareholding
8th Jul 20255:06 pmRNSDirector/PDMR Shareholding
1st Jul 20259:58 amRNSTotal Voting Rights
1st Jul 20257:09 amRNSSSENT response to RIIO-T3 Draft Determination

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.